angiotensin ii, des-asp(1)-des-arg(2)-ile(5)- has been researched along with amastatin in 5 studies
Studies (angiotensin ii, des-asp(1)-des-arg(2)-ile(5)-) | Trials (angiotensin ii, des-asp(1)-des-arg(2)-ile(5)-) | Recent Studies (post-2010) (angiotensin ii, des-asp(1)-des-arg(2)-ile(5)-) | Studies (amastatin) | Trials (amastatin) | Recent Studies (post-2010) (amastatin) |
---|---|---|---|---|---|
311 | 5 | 64 | 183 | 0 | 19 |
Protein | Taxonomy | angiotensin ii, des-asp(1)-des-arg(2)-ile(5)- (IC50) | amastatin (IC50) |
---|---|---|---|
Aminopeptidase N | Sus scrofa (pig) | 1.1 | |
Angiotensin-converting enzyme | Rattus norvegicus (Norway rat) | 1.1 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (60.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Li, Q; Pfaffendorf, M; van Zwieten, PA; Zhang, J | 1 |
Eijsman, L; Feenstra, M; Li, Q; Pfaffendorf, M; van Zwieten, PA | 1 |
Cerullo, G; Colucci, M; Gesualdo, L; Grandaliano, G; Monno, R; Ranieri, E; Rossiello, MR; Schena, FP; Semeraro, N; Ursi, M | 1 |
Ito, S; Sved, AF | 1 |
Li, Q; Pfaffendorf, M; van Zwieten, PA | 1 |
5 other study(ies) available for angiotensin ii, des-asp(1)-des-arg(2)-ile(5)- and amastatin
Article | Year |
---|---|
Direct positive chronotropic effects of angiotensin II and angiotensin III in pithed rats and in rat isolated atria.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Angiotensin II; Angiotensin III; Angiotensin Receptor Antagonists; Animals; Anti-Bacterial Agents; Decerebrate State; Heart Atria; Heart Rate; In Vitro Techniques; Injections, Intravenous; Male; Peptides; Prazosin; Propranolol; Rats; Rats, Wistar; Stimulation, Chemical; Vasoconstrictor Agents | 1996 |
Comparative vasoconstrictor effects of angiotensin II, III, and IV in human isolated saphenous vein.
Topics: Aged; Aged, 80 and over; Aminopeptidases; Angiotensin II; Angiotensin III; Angiotensin Receptor Antagonists; Anti-Bacterial Agents; Antihypertensive Agents; Biphenyl Compounds; Dose-Response Relationship, Drug; Drug Synergism; Female; Glutamyl Aminopeptidase; Humans; Imidazoles; In Vitro Techniques; Losartan; Male; Metalloendopeptidases; Methionyl Aminopeptidases; Middle Aged; Muscle Contraction; Muscle, Smooth, Vascular; Peptides; Protease Inhibitors; Pyridines; Saphenous Vein; Tachyphylaxis; Tetrazoles; Vasoconstrictor Agents | 1997 |
Angiotensin IV stimulates plasminogen activator inhibitor-1 expression in proximal tubular epithelial cells.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Anti-Bacterial Agents; Antihypertensive Agents; Blotting, Northern; Cell Division; Cell Line, Transformed; Epithelial Cells; Fibrosis; Gene Expression; Humans; Kidney Diseases; Kidney Tubules, Proximal; Losartan; Peptides; Plasminogen Activator Inhibitor 1; Protease Inhibitors; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; RNA, Messenger; Tissue Plasminogen Activator; Transforming Growth Factor beta; Urokinase-Type Plasminogen Activator | 1999 |
Pharmacological profile of depressor response elicited by sarthran in rat ventrolateral medulla.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Anti-Bacterial Agents; Antihypertensive Agents; Blood Pressure; Dose-Response Relationship, Drug; GABA Antagonists; Losartan; Male; Medulla Oblongata; Muscimol; Peptides; Protease Inhibitors; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Vasoconstrictor Agents | 2000 |
Different types of antagonism by losartan and irbesartan on the effects of angiotensin II and its degradation products in rabbit arteries.
Topics: Angiotensin II; Angiotensin III; Angiotensin Receptor Antagonists; Animals; Anti-Bacterial Agents; Antihypertensive Agents; Biphenyl Compounds; Endothelium, Vascular; Femoral Artery; Imidazoles; In Vitro Techniques; Irbesartan; Leucine; Losartan; Male; Peptides; Protease Inhibitors; Pyridines; Rabbits; Receptor, Angiotensin, Type 1; Renal Artery; Tetrazoles; Vasoconstrictor Agents | 2001 |